Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-03

Clinical Trial Update: Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ciclosporin versus alitretinoin for severe hand atopic dermatitis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alitretinoin (alitretinoin)
  • CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Atopic Dermatitis | Phase 4 | Status: TERMINATED